Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects
|
|
- Hester McDonald
- 6 years ago
- Views:
Transcription
1 Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects Seventeen infants were treated with inhaled nitric oxide for critical pulmonary artery hypertension after operations for congenital heart defects. In au 17 patients conventional medical therapy consisting of hyperventilation, deep sedation/analgesia, and correction of metabolic acidosis had failed. AlI children were monitored with a transthoracic pulmonary artery catheter inserted at operation. Pulmonary artery hypertension was defined as an acute rise in pulmonary pressure associated with a decrease in oxygen arterial or venous saturation. After failure of conventional medical therapy, 20 ppm of inhaled nitric oxide was administered to the patient. In au patients the pulmonary pressures decreased (mean pulmonary arterial pressure decreased by -34 % ± 21 % ) without significant change in systemic arterial pressure, whereas the oxygen arterial saturation and oxygen venous saturation increased by 9.7% ± 12% and 37% ± 28%, respectively. Fifteen children were discharged from the intensive care unit at 10 ± 6 days (range 3 to 26 days) and two died. This study demonstrates that inhaled nitric oxide exerts a selective pulmonary vasodilation without decreasing systemic arterial pressure in children with congenital heart disease. The increased values of mixed venous oxygen saturation and urinary output suggest that this selective lowering of pulmonary vascular resistance iqlproved the overall hemodynamics. The potential toxic effects of nitric oxide and nitrogen dioxide necessitate careful consideration of the risks and benefits of inhaled nitric oxide therapy. (J THoRAc CARDIOVASC SURG 1994;107:1129-) Didier Journois, MD,a Philippe Pouard, MD,a Philippe Mauriat, MD,a Thierry Malhere, MD,a Pascal Vouh6, MD,b and Denis Safran, MD,a Paris, France Ater neonatal cardiac operations for certain congenital heart defects, a critical rise in pulmonary artery pressure (PAP) may occur. 1 3 Despite aggressive therapy with manual hyperventilation, deep levels of analgesia and sedation, muscle paralysis and vasodilator therapy, the mortality remains usually high when major hypertensive crises occur.2, 3 Furthermore, pulmonary artery vasodilator therapy is often nonselective and may produce systemic hypotension, partially contributing to the morbidity.2-4 From the Departments of Anesthesia and Intensive Care Medicine a and,b H6pital Laennec, Paris, France. Received for publication Feb. 22, Accepted for publication Oct. 5, Address for reprints: Didier lournois, MD, H6pital Laennec, 42, rue de Sevres, 3 Paris, France. Copyright 1994 by Mosby-Year Book, Inc /94 $ /1/52225 Recent reports have demonstrated that nitric oxide is a selective pulmonary vasodilator in adults 5, 6 and in newborn infants. 7 The usefulness of nitric oxide has been suggested by several isolated case reports after pediatric cardiac operations We therefore systematically evaluated the hemodynamic changes during inhalation of low concentrations of nitric oxide in the treatment of postoperative pulmonary hypertensive crises after repair of congenital heart defects. Patients and methods A pulmonary arterial catheter was inserted transthoracically via the right ventricular myocardium in 42 children thought to be at risk for postoperative pulmonary hypertension.! Twenty of these catheters were 4F fiberoptic pulmonary artery catheters that allowed continuous mixed venous oxygen saturation measurement (SV02; Oximetrix Lab., Abbott Laboratories, North Chicago, 111.).11 After operation, central venous and left atrial pressures, systemic arterial pressure, systemic arterial saturation by pulse oximetry, and body temperature were continuously monitored. Blood gas analysis was done at least every 6 hours. 1 I 29
2 I I Journois et al. The Journal of Thoracic and April 1994 Table I. Demographic data Weight Stay in/cu Extubation timing Patient No. Diagnosis Age (kg) Survival Complication (days) (days) I Total APVR 6 days 3.2 Yes No VSD lib II rno 6.5 Yes No TotalAPVR days 3.0 Yes No Total APVR 5 days 3.0 Yes Infection TA+VSD 20 days 3.4 Yes No TotalAPVR days 3.6 Yes No 3 7 APVR + VSD + IAA 10 days 4.5 Yes No VSD + IAA 15 days 3.1 Died Tracheornalacia 9 9 AVCD 2rno 4.0 Yes No AVCD 3 rno 4.5 Died Infection 12 II LAO 18 rno 9.2 Yes Infection VSD days 3.5 Yes No TotalAPVR 5 days 3.2 Yes No AVCD 4rno 4.9 Yes No AVCD 2 yr 12 Yes No TA 14 days 3.3 Yes Infection VSD 2rno 3.7 Yes No 5 3 Mean ± SD 4.6 ± ± 6 6±6 ICU. Intensive care unit;apvr, anomalous pulmonary venous return; VSD, ventricular septal defect; T A, truncus arteriosus; IAA, interrupted aortic arch; AVCD, atrioventricular canal defects; LAO, left atrium obstruction after a Senning operation; SD, standard deviation. The arterial pulse oximetry was continuously monitored. The lungs were ventilated with a Siemens Servo 900C ventilator (Siemens-Elema, Division of Elema-Schiinander, Inc., Solna, Sweden) with an inspired oxygen fraction (Fio2) of 1 and slightly hyperventilated to reach an arterial carbon dioxide tension of approximately mm Hg. Continuous infusions of pancuronium and fentanyl were administered during the first 12 postoperative hours. Dobutamine or dopamine, or both, infused at rates less than or equal to 5 f.lg kg-i. min- 1 were used as inotropic agents in several patients at the end of cardiopulmonary bypass. Conventional management of acute pulmonary hypertension crisis was instituted if PAP exceeded % of systemic pressure in association with a decrease in SV02 and/or arterial (Sao2) oxygen saturation. This therapy included 100% oxygen with manual ventilation, deepening the level of anesthesia, and correction of the metabolic acidosis with sodium bicarbonate administration. After 5 minutes of unsuccessful therapy, inhaled nitric oxide was administered. The measured variables during nitric oxide administration were heart rate; systolic, diastolic, and mean systemic arterial pressures (AP); systolic, diastolic, and mean PAPs; central venous pressure; left atrial pressure; urinary output; and venous and arterial blood gases. A complete set of measurements was recorded before (To) and 20 minutes after administration of 20 ppm of inhaled nitric oxide (Tl). Nitric oxide administration was continued until pulmonary artery hypertension was absent for 6 hours in the face of tracheal suctioning, progressive weaning of sedation, and progressive reduction of Fio2. Persistence of a low SV02, a low Sao2 or a high mean PAP/mean AP ratio was treated by increasing the inspired nitric oxide fraction from 20 ppm to ppm. Further sets of measurements were recorded every hour or in the event of paroxysmal pulmonary hypertension crisis. Methemoglobin concentration was measured twice daily. A tank containing 225 ppm of nitric oxide in nitrogen (Compagnie Fran~aise des Produits Oxygenes, Paris, France) was connected to a specially designed low-flow blender. The mixture of nitric oxide and nitrogen was continuously delivered through a needle inserted at the end of the inspiratory limb into the breathing circuit. A 1.0 (16 cases) or a 1.5 mm (1 case) external diameter catheter was inserted into the tracheal tube and positioned 1 cm from its distal extremity. The catheter was connected to an oxygen/nitrogen analyzer (Servo gas monitor 120, Siemens) via an electrochemical nitric oxide/nitrogen dioxide analyzer (Polytron NO/N02, Drager, Antony, France), which allowed continuous measurements of Fi02, nitric oxide, nitrogen dioxide, and nitrogen. The gas aspiration rate for analysis of 105 ml. min- 1 was compensated by an equivalent increase in ventilation. The flow of the nitric oxide/ nitrogen mixture was adjusted to achieve the desired inhaled nitric oxide concentration. After extubation, if PAP remained elevated, nitric oxide was given by means of a facial mask. Expired and analyzer's gases were scavanged. This investigation was done with approval of the hospital review board and informed consent was obtained from each infant's family. Data are expressed as mean ± standard deviation and were compared between To and Tl by Wilcoxon test for paired values. Further measurements were compared by analysis ofvariance for repeated measures followed by a two-tailed Dunnett's post-hoc test with To as control value. Comparisons between the two patient groups used Wilcoxon or Fisher's exact test. The relationship between nitric oxide and nitrogen dioxide concentrations was studied by linear regression. A p value less than 0.05 was considered statistically significant. Results Seventeen children with pulmonary artery hypertension, from 5 days to 24 months of age (median days), in whom conventional medical therapy had failed, were
3 The Journal of Thoracic and Volume 107, Number 4 Journois et ai, spap mpap ~ 25 T T1 T1 Fig. 1. Evolution of PAPs between To (before nitric oxide) and TJ (after nitric oxide). spap, Systolic PAP; mpap, mean PAP; dp AP, diastolic PAP. sap map 95 dap T1 T1 T1 Fig. 2. Evolution of systemic APs between To (before nitric oxide) and TJ (after nitric oxide). sap, Systolic AP; map, mean AP; dap, diastolic AP. studied. Demographic data and description of congenital heart diseases are reported in Table I. Inhaled nitric oxide resulted in significant decreases in systolic PAP (-32% ± 16%), mean PAP (-34% ± 21 %), and diastolic PAP (-43% ± 20%) (Fig. I), whereas no significant change was observed in systolic, mean, or diastolic AP (Table II, Fig. 2). Significant increases were observed in Sao2 (+9.7% ± 12%) and SV02 ( + 37% ± 28%) despite a reduction of Fio2 from 1 to 0.92 ± 0.1 as a result of inhaled nitric oxide administration (Fig. 3 and Table III). The mean PAP/mean AP ratio decreased from 0.76 ± 0.21 to 0.49 ± 0.18 at Tl (-34%; Fig. 4). Urinary output increased from 1.4 ± 1.2 to 2.8 ± 1.3 ml. kg-i. hr- 1 at the third hour after the institution of inhaled nitric oxide (p < 0.05). In three children, a dramatic decrease in mean AP was observed (Fig. 2) in association with an increase in Sao2, SV02, and urinary output. A secondary rise in PAPs was ob-
4 J oumois et al. The Journal of Thoracic and April % Sa02 Sv02 T1 T1 Fig. 3. Evolution of Saoz and SV02 between To (before nitric oxide) and Tl (after nitric oxide). 70 Y served during sedation weaning in six children. Increasing of inhaled nitric oxide concentration from 20 ppm to ppm failed to normalize PAPs in five of these six. Patients were treated by inhaled nitric oxide for 44 ± 69 hours (range 4 to 2). All patients were eventually weaned from inotropic drugs, vasodilators, highlevel sedation, and high Fio 2 In three patients pulmonary infections subsequently developed after the initial period of hemodynamic instability ended. Nine of the children recovered and two children died (one of infection and the other of upper respiratory tract problems). In one child, the autopsy revealed a severe pulmonary infection. Except for minor suction wounds, the trachea was histologically normal. Fifteen children were discharged from the intensive care unit at 10 ± 6 days (range 3 to 26 days). In 238 measurements near the tracheal outlet of the endotracheal tube, nitric oxide concentration was 22.2 ± 14 ppm (range 8.5 to ) and nitric oxide 1.41 ± 1.8 ppm (range 0.1 to 8.2). Linear regression showed a strong relationship between nitric oxide and nitrogen dioxide concentrations (nitrogen dioxide = X nitric oxide - 0.1; P = ). The highest methemoglobin concentration was 1.8%. No other side effects were observed. Table II. Evolution of hemodynamic data between To and T] To TJ (before NO) (20 min after NO) p Value HR (beats. min-l) 153 ± 22 1 ± Systolic PAP (mm ± 14 ± Mean PAP (mm 42 ± ± Diastolic PAP (mm 31 ± ± Systolic AP (mm 68 ± ± Mean AP (mm ± ± Diastolic AP (mm 44 ± ± LAP () 7.2 ± ± CVP () 6.6 ± ± SV02 (%) ± ± Sao2 (%) 87 ± 8 96 ± Data are expressed as means ± standard deviation. NO, Nitric oxide; HR, heart rate; PAP, systolic pulmonary arterial pressure; LAP, left atrial pressure; CVP, central venous pressure; SV02, mixed venous blood oxygen saturation; Sao2, arterial oxygen saturation. Discussion This study confirms that inhaled nitric oxide exerts a selective pulmonary vasodilation without decreasing systemic AP even in neonates and infants with pulmonary artery hypertension after repair of congenital heart disease. The improvement in SV02 and urinary output suggests that the selective lowering of pulmonary vascular resistance promoted a better hemodynamic condition. Because oxygen consumption and hemoglobin levels are likely to remain nearly constant, this SV02 increase is probably caused by both increases in Sao2 and cardiac output. Although cardiac output was not measured, an improvement in the right ventricular function is probably responsible for this effect. l This phenomenon, in association with an increased Sao2, might improved arterial oxygen transport. Furthermore, inhaled nitric oxide may specifically dilate pulmonary vessels next to ventilated alveoli, enhancing ventilation-perfusion matching. Prolonged postoperative anesthesia has been demonstrated to control episodes of pulmonary artery hypertension in response to tracheal stimulation. l2 This technique requires several days for pulmonary artery reactivity to decrease and may facilitate pulmonary infections. In our study, inhaled nitric oxide seemed to be effective as a sole therapy and allowed discontinuation of vasodilators, inotropic support, and lightening of anesthesia. We speculate that this therapy may reduce durations of ventilatory support and intensive care unit stay in patients at risk for pulmonary artery hypertension.
5 The Journal of Thoracic and Volume 107, Number 4 Journois et al. 1 I 3 3 Table III. Evolution of blood gases and respiratory data between To and TJ To (before NO) TJ (20 min after NO) p Value Fioz 0.99 ± ± O.oI5 < Bicarbonate 25.6 ± ± (mmoljl) Paco2 (mm 24.8 ± ± ph ± ± Respiratory rate 43.9 ± ± (counts/min) Pressure plateau (em 23. ± ± 3. < H2O) Pressure peak (em ± ± 3.9 < H2O) Minute ventilation 2917± ± (mljrnin) Comparisons with paired Student's I test. Data are expressed as means ± standard deviation. Paeo], Arterial carbon dioxide tension; 0.9 ~ m vs, P = Fig. 4. Evolution of mean PAP / mean AP ratio (mp AP/mAP) over time after inhaled nitric oxide administration. Data are expressed as mean and standard deviation. * p < 0.05 versus To..' An important characteristic of pulmonary artery hypertension is its paroxysmal nature. I This may be due to the auto-intensification of pulmonary artery hypertension, mediated by hypoxemia, that is a major cause of pulmonary vasoconstriction in young children. 13 Pulmonary artery hypereactivity seems to persist several days after a complete surgical correction that should eliminate the cause of pulmonary hypertension. 3 This phenomenon suggests the coexistence of an abnormality in arterial reactivity induced by the congenital heart disease. 14 It seems to occur in association with an increase in medial thickness resulting from preexisting elevated pulmonary arterial pressure. 14,15 Furthermore, hypoxemia and increased pulmonary blood flow induce the persistence of fetal pulmonary vascular muscularization in neonates. 16 Abnormalities in endothelin-derived relaxing factor or in endothelin releaseshave also been suggested. 17, 18 Most of these abnormalities usually do not persist more than a few days after surgical correction. 3, 18 A therapeutic aim of inhaled nitric oxide administration, therefore, is stabilization until pulmonary arterial reactivity is reduced after operation. 1 Oxygen inhalation is an effective pulmonary vasodilator when pulmonary hypertension is due to a hypoxic stimulation of precapillary arteriolar vasculature. 4 The reduction in Fio2 that inhaled nitric oxide allows is of particular interest in neonates in whom high Fio2s are deleterious. Correction of acidosis is also necessary to repress the pulmonary arterial reactivity. I This is achieved by prevention of low cardiac output, which inhaled nitric oxide provides. Many pharmacologic agents have been reported to have pulmonary vasodilating properties, including a-blockers,19 tolazoline,4 (3-agonists,2D nitrates,21,22 calcium channel blockers,23 and.prostaglandins. 24 All these agents induce tissue edema and a systemic vasodilation. I, 7, 25 These deleterious effects can be partially counteracted by combining their infusion with norepinephrine. 24 Furthermore, the frequent association of atrial or ventricular right-to-left shunts during pulmonary hypertension crisis leads to shunting of increased levels of the administered vasodilators toward the systemic circulation.! This may lead to a predominant systemic vasodilation that is particularly undesirable inasmuch as left ventricular output is simultaneously impaired by the pulmonary hypertension-induced preload reduction. Ultimately, when pulmonary hypertension crisis persists despite the optimal use of these pharmacologic agents, extracorporeal membrane oxygenator support has been proposed as a last resort to avoid the complications of these therapies.! Nitric oxide produces vasodilation by directly activating guanylate cyclase, which increases the intracellular cyclic guanosine 3,5-monophosphate levels in smooth muscle cells and produces vasodilation. 26 The rapid nitric oxide inactivation by the hemoglobin contained in the pulmonary blood vessels 27 explains its short-acting and local effects. Inhaled nitric oxide doses in human beings appear safe. 5, 7, 8, 25, 28, 29 Nevertheless, nitric oxide is known to be a toxic gas. 3D Major toxic effects have been described with high nitric oxide concentrations (,000 ppm).3! They involve bronchial and tracheal damage,3! methemoglobinemia,3! and nitrogen dioxide and peroxynitrite pro-
6 lournois et al. The Journal of Thoracic and April 1994 duction. 32, 33 Methemoglobinemia levels were low in our study. Because exposure to only 2 ppm of nitrogen dioxide during 24 hours induces ciliary depletion and bronchial dysplasia,34 maximal continuous inhaled nitric oxide concentration should be limited to 20 ppm or strictly restricted to crisis treatment. Administration of nitric oxide can be beneficial in treatment of patients with certain congenital heart defects. The small number of patients in this study does not permit any subgroup analysis to determine which congenital heart defects are appropriate for therapy with inhaled nitric oxide. At low doses, inhaled nitric oxide is effective, simple to use, and had no serious adverse effect. Inhaled nitric oxide has therapeutic potential in postoperative pulmonary artery hypertension after operations for congenital heart disease. Nevertheless, risks and benefits of inhaled nitric oxide need careful consideration. Further tolerance studies are required. We thank W. 1. Greeley, MD, Associate Professor of Anesthesiology and Pediatrics, Duke University Medical Center, Durham, N.C., for his valuable advice and comments; and the staff and the nurses of our Intensive Care Unit for their support. REFERENCES I. Hopkins R, Bull C, Haworth S, de Leval MR, Stark 1. Pulmonary hypertensive crises following surgery for congenital heart defects in young children. Eur 1 Cardiothorac Surg 1991;5: nes 0, Shore D, Rigby M, et al. The use of tolazoline hydrochloride as a pulmonary vasodilator in potentially fatal episodes of pulmonary vasoconstriction after cardiac surgery in children. Circulation 1981;64: Wheller 1, George B, Muller D, larmakani 1. Diagnosis and management of postoperative pulmonary hypertensive crisis. Circulation 19;: Goetzman B, Sunshine P, 10hnson 1, et al. Neonatal hypoxia and pulmonary vasospasm response to tolazoline. 1 Pediatr 1976;89: Rich G, Murphy G, Roos C, 10hns R. Inhaled nitric oxide: selective pulmonary vasodilatation in cardiac surgical patients. Anesthesiology 1993;78: Pepke-Zaba 1, Higenbottam T, Dinh-Zuan A. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991;338: Roberts 1, Polaner D, Lang P, Zapol W. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;3: Sellden H, Winberg P, Gustafsson L, Lundell B, Book K, Frostell C. Inhalation of nitric oxide reduced pulmonary hypertension after cardiac surgery in a 3.2 kg infant. Anesthesiology 1993;78: Berner M, Beghetti M, Ricou B, Rouge 1, Pretre R, Friedli B. Relief of severe pulmonary hypertension after closure of a large ventricular septal defect using low dose inhaled nitric oxide. Intensive Care Med 1993;19: Haydar A, Mauriat P, 10urnois D, Pouard P, Safran D, Vouhi: P. Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects [Abstract). Lancet 1992;3: Rah K, Dunwiddie W, Lower R. A method for continuous postoperative measurement of mixed venous saturation in infants and children after open heart procedures. Anesth Analg 1984;63: Hickey P, Hansen D, Wessel D, Lang P, 10nas R, Elixson E. Blunting of stress responses in the pulmonary circulation in infants by fentanyl. Anesth Analg 1985;64: lames L, Rowe R. The pattern of response of pulmonary and systemic arterial pressures in newborn and older infants to short periods of hypoxia. 1 Pediatr 1957;51: Haworth S. Normal pulmonary vascular development and its disturbance in congenital heart disease. In: Goodman M, ed. Pediatric cardiology. New York: Churchill-Livingstone, 1981: Meyrick B, Reid L. Ultrastructural findings in lung biopsy material from children with congenital heart defects. Am 1 PathoI19;101: Emmanouilides G, Moss A, Duffie E. Pulmonary arterial pressure changes in human newborn infants from birth to 3 days of age. 1 Pediatr 1964;: Abman S, Chatfield B, Hall S, McMurtry I. Role ofedrf during transition of pulmonary circulation at birth. Am 1 Physiol 1 990;259:H Yoshibayashi M, Nishioka K, Nakao K, et al. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Circulation 1991;84: Artman M, Parrish M, Boerth R, Boucek R, Graham T. Short-term hemodynamic effects of hydralazine in infants with complete atrioventricular canal defects. Circulation 1984;69: Pietro D, Bresh KL, Shulman R, Folland E, Parisi A, Sasahara A. Sustained improvement in primary pulmonary hypertension during six years of treatment with sublingual isoproterenol. N Engl 1 Med 1984;310: Damen 1, Hitchcock 1. Reactive pulmonary hypertension after a switch operation: successful treatment with glyceryl trinitrate. Br Heart ;53: Bixler T, Gott V, Gardner T. Reversal of experimental pulmonary hypertension with sodium nitroprusside. 1 THO RAC CARDIOVASC SURG 1981;81: De Freyter Pl, Kerkkamp H, long ld. Sustained beneficial effect of nifedipine in primary pulmonary hypertension. Am Heart ;105: D' Ambra M, Rain PL, Philbin D, Watkins W, Hilgenberg A, Buckley M. Prostaglandin EI: a new therapy for refractory right heart failure and pulmonary hypertension after mitral valve replacement. 1 THORAC CARDIOV ASC SURG 1985;89: Kinsella 1. Low-dose inhalational nitric oxide in persistent
7 The Journal of Thoracic and Volume 107, Number 4 lournois et al pulmonary hypertension of the newborn. Lancet 1992; 3: Ignarro L. Biological actions and properties of endothelialderived nitric oxide formed and released from artery and vein. Circ Res 1989;: Gruetter C, Gruetter D, Lyon J, Ignarro L. Relationship between cyclic guanosine 3,5-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide. J Pharmacol Exp Ther 1981;219: Girard C, Lehot J, Pannetier J, Filley S, French P, Estanove S. Inhaled nitric oxide after mitral replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992;77: Frostell C, Blomqvist H, Hedepstierna G, Lundberg J, Zapol W. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 1993;78: Clutton-Brock J. Two cases of poisoning by contamination of nitrous oxide with higher oxides of nitrogen during anaesthesia. Br J Anaesth 1967;39: Greenbaum R, Bay J, Hargreaves M, et al. Effects of higher oxides of nitrogen on the anaesthetized dog. Br J Anaesth 1967;39: Austin A. The chemistry of the higher oxides of nitrogen as related to the manufacture, storage and administration of nitrous oxide. Br J Anaesth 19;39: Beckman J, Beckman T, Chen J, Marshall P, Freeman B. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87: Stephens R, Freeman G, Evans M. Early response of lungs to low levels of nitrogen dioxide. Arch Environ Health 1972;24: 1-79.
Pulmonary hypertension is a significant cause of morbidity
Randomized Controlled Study of Inhaled Nitric Oxide After Operation for Congenital Heart Disease Ronald W. Day, MD, John A. Hawkins, MD, Edwin C. McGough, MD, Kevin L. Crezeé, RRT, and Garth S. Orsmond,
More informationino in neonates with cardiac disorders
ino in neonates with cardiac disorders Duncan Macrae Paediatric Critical Care Terminology PAP Pulmonary artery pressure PVR Pulmonary vascular resistance PHT Pulmonary hypertension - PAP > 25, PVR >3,
More informationSCVMC RESPIRATORY CARE PROCEDURE
Page 1 of 7 New: 12/08 R: 4/11 R NC: 7/11, 7/12 B7180-63 Definitions: Inhaled nitric oxide (i) is a medical gas with selective pulmonary vasodilator properties. Vaso-reactivity is the evidence of acute
More informationNothing to Disclose. Severe Pulmonary Hypertension
Severe Ronald Pearl, MD, PhD Professor and Chair Department of Anesthesiology Stanford University Rpearl@stanford.edu Nothing to Disclose 65 year old female Elective knee surgery NYHA Class 3 Aortic stenosis
More informationPerioperative Management of TAPVC
Perioperative Management of TAPVC Professor Andrew Wolf Rush University Medical Center,Chicago USA Bristol Royal Children s Hospital UK I have no financial disclosures relevant to this presentation TAPVC
More informationMechanical Ventilation & Cardiopulmonary Interactions: Clinical Application in Non- Conventional Circulations. Eric M. Graham, MD
Mechanical Ventilation & Cardiopulmonary Interactions: Clinical Application in Non- Conventional Circulations Eric M. Graham, MD Background Heart & lungs work to meet oxygen demands Imbalance between supply
More informationInhaled Nitric Oxide for Children With Congenital Heart Disease and Pulmonary Hypertension
Inhaled Nitric Oxide for Children With Congenital Heart Disease and Pulmonary Hypertension Ronald D. Curran, MD, Constantine Mavroudis, MD, Carl L. Backer, MD, Michael Sautel, BS, Vincent R. Zales, MD,
More informationBeneficial Effects of Inhaled Nitric Oxide in Adult Cardiac Surgical Patients
Beneficial Effects of Inhaled Nitric Oxide in Adult Cardiac Surgical Patients Thomas S. Maxey, MD, Christopher D. Smith, MBBS, FRACS, John A. Kern, MD, Curtis G. Tribble, MD, David R. Jones, MD, Irving
More informationDIPYRIDAMOLE ATTENUATES REBOUND PULMONARY HYPERTENSION AFTER INHALED NITRIC OXIDE WITHDRAWAL IN POSTOPERATIVE CONGENITAL HEART DISEASE
DIPYRIDAMOLE ATTENUATES REBOUND PULMONARY HYPERTENSION AFTER INHALED NITRIC OXIDE WITHDRAWAL IN POSTOPERATIVE CONGENITAL HEART DISEASE D. Dunbar Ivy, MD a John P. Kinsella, MD b James W. Ziegler, MD d
More informationTreatment of Acute Pulmonary Hypertension With Inhaled Nitric Oxide
Treatment of Acute Pulmonary Hypertension With Inhaled Nitric Oxide Martin Tonz, MD, Ludwig K. von Segesser, MD, Julian Schilling, MD, Thomas F. Luscher, MD, Georg Noll, MD, Boris Leskosek, BA, and Marko
More informationPulmonary Vasodilator Treatments in the ICU Setting
Pulmonary Vasodilator Treatments in the ICU Setting Lara Shekerdemian Circulation 1979 Ann Thorac Surg 27 Anesth Analg 211 1 Factors in the ICU Management of Pulmonary Hypertension After Cardiopulmonary
More informationAnatomy & Physiology
1 Anatomy & Physiology Heart is divided into four chambers, two atrias & two ventricles. Atrioventricular valves (tricuspid & mitral) separate the atria from ventricles. they open & close to control flow
More informationNitric Resource Manual
Nitric Resource Manual OBJECTIVES Describe the biologic basis for inhaled nitric oxide therapy Describe the indications for inhaled nitric oxide therapy Describe the potential hazards, side effects and
More informationUSE OF INHALED NITRIC OXIDE IN THE NICU East Bay Newborn Specialists Guideline Prepared by P Joe, G Dudell, A D Harlingue Revised 7/9/2014
USE OF INHALED NITRIC OXIDE IN THE NICU East Bay Newborn Specialists Guideline Prepared by P Joe, G Dudell, A D Harlingue Revised 7/9/2014 ino for Late Preterm and Term Infants with Severe PPHN Background:
More informationIntroduction. Invasive Hemodynamic Monitoring. Determinants of Cardiovascular Function. Cardiovascular System. Hemodynamic Monitoring
Introduction Invasive Hemodynamic Monitoring Audis Bethea, Pharm.D. Assistant Professor Therapeutics IV January 21, 2004 Hemodynamic monitoring is necessary to assess and manage shock Information obtained
More informationIn newborns with a functional single ventricle and
Pulmonary Vascular Resistance of Children Treated With Nitrogen During Early Infancy Ronald W. Day, MD, Alan J. Barton, MD, Theodore J. Pysher, MD, and Robert E. Shaddy, MD Division of Pediatric Cardiology,
More informationKeep. with life MEDICATION TECHNOLOGY SERVICES INSPIRED BY YOUR NEEDS
Keep with life MEDICATION TECHNOLOGY SERVICES INSPIRED BY YOUR NEEDS 2 KINOX MEDICATION KINOX, inhaled nitric oxide, is a selective pulmonary vasodilator developed by Air Liquide Healthcare and characterized
More informationPulmonary circulation. Lung Blood supply : lungs have a unique blood supply system :
Dr. Ali Naji Pulmonary circulation Lung Blood supply : lungs have a unique blood supply system : 1. Pulmonary circulation 2. Bronchial circulation 1- Pulmonary circulation : receives the whole cardiac
More informationPULMONARY ARTERY HYPERTENSION (PAH) leading
Inhaled Nitroglycerin Versus Inhaled Milrinone in Children with Congenital Heart Disease Suffering from Pulmonary Artery Hypertension Raveen Singh, MD,* Minati Choudhury, MD,* Anita Saxena, DM, Poonam
More informationTopics to be Covered. Cardiac Measurements. Distribution of Blood Volume. Distribution of Pulmonary Ventilation & Blood Flow
Topics to be Covered MODULE F HEMODYNAMIC MONITORING Cardiac Output Determinants of Stroke Volume Hemodynamic Measurements Pulmonary Artery Catheterization Control of Blood Pressure Heart Failure Cardiac
More informationInhaled Nitric Oxide Beyond the Evidence- Children
Critical Care Canada Forum, Toronto 2014 Inhaled Nitric Oxide Beyond the Evidence- Children Ian Adatia, Pediatric Pulmonary Hypertension Service and Cardiac Intensive Care Unit, Stollery Children s Hospital,
More informationSurgical Approaches to Advanced Pulmonary Vascular Disease. Historical Perspectives. Historical Perspectives
5 th International Conference Neonatal and Childhood Pulmonary Vascular Disease, San Francisco, March 9-10, 2012 Surgical Approaches to Advanced Pulmonary Vascular Disease William M. Novick, M.D., M.S.
More informationEarlier Use of Inhaled Nitric Oxide in Term and Near-Term Neonates With Hypoxic Respiratory Failure (HRF) and Pulmonary Hypertension (PH)
Earlier Use of Inhaled Nitric Oxide in Term and Near-Term Neonates With Hypoxic Respiratory Failure (HRF) and Pulmonary Hypertension (PH) 2013 Ikaria, Inc. 1 Disclosure Information This program is sponsored
More informationScreening for Critical Congenital Heart Disease
Screening for Critical Congenital Heart Disease Caroline K. Lee, MD Pediatric Cardiology Disclosures I have no relevant financial relationships or conflicts of interest 1 Most Common Birth Defect Most
More information1
1 2 3 RIFAI 5 6 Dublin cohort, retrospective review. Milrinone was commenced at an initial dose of 0.50 μg/kg/minute up to 0.75 μg/kg/minute and was continued depending on clinical response. No loading
More informationPathophysiology: Left To Right Shunts
Pathophysiology: Left To Right Shunts Daphne T. Hsu, MD dh17@columbia.edu Learning Objectives Learn the relationships between pressure, blood flow, and resistance Review the transition from fetal to mature
More informationWeeks 1-3:Cardiovascular
Weeks 1-3:Cardiovascular Cardiac Output The total volume of blood ejected from the ventricles in one minute is known as the cardiac output. Heart Rate (HR) X Stroke Volume (SV) = Cardiac Output Normal
More informationLecture Notes. Chapter 2: Introduction to Respiratory Failure
Lecture Notes Chapter 2: Introduction to Respiratory Failure Objectives Define respiratory failure, ventilatory failure, and oxygenation failure List the causes of respiratory failure Describe the effects
More informationPFIZER INC. Study Center(s): A total of 6 centers took part in the study, including 2 in France and 4 in the United States.
PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. For publications based on this study, see associated bibliography.
More informationVariable Response to Inhaled Nitric Oxide After Cardiac Surgery
Variable Response to Inhaled Nitric Oxide After Cardiac Surgery David A. Fullerton, MD, James Jaggers, MD, Mary M. Wollmering, MD, Fran Piedalue, RRT, Frederick L. Grover, MD, and Robert C. McIntyre, Jr,
More informationPerioperative Management of DORV Case
Perioperative Management of DORV Case James P. Spaeth, MD Department of Anesthesia Cincinnati Children s Hospital Medical Center University of Cincinnati Objectives: 1. Discuss considerations regarding
More informationINHALED NITRIC OXIDE AND PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN INHALED NITRIC OXIDE AND PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN
INHALED NITRIC OXIDE AND PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN INHALED NITRIC OXIDE AND PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN JESSE D. ROBERTS, JR., M.D., JEFFREY R. FINEMAN, M.D.,
More informationSurgical Repair of Transposition of the Great Arteries in Neonates With Persistent Pulmonary Hypertension
Surgical Repair of Transposition of the Great Arteries in Neonates With Persistent Pulmonary Hypertension Giovanni Battista Luciani, MD, Anthony C. Chang, MD, and Vaughn A. Starnes, MD Divisions of Cardiothoracic
More informationPost-Cardiac Surgery Evaluation
Post-Cardiac Surgery Evaluation 20th Annual Heart Conference October 15, 2016 Gary A Mayman PROFESSOR PEDIATRICS UNIVERSITY OF NEVADA Look Touch Listen Temperature, pulse, respiratory rate, & blood pressure
More informationPathophysiology: Left To Right Shunts
Pathophysiology: Left To Right Shunts Daphne T. Hsu, MD dh17@columbia.edu Learning Objectives Learn the relationships between pressure, blood flow, and resistance Review the transition from fetal to mature
More informationLate Results after Correction of Ventricular Septal Defect with Severe Pulmonary Hypertension
Tohoku J. Exp. Med., 1994, 174, 41-48 Late Results after Correction of Ventricular Septal Defect with Severe Pulmonary Hypertension KIYOSHI HANEDA, NAOSHI SATO, TAKAO TOGO, MAKOTO MIURA, MASAKI RATA and
More informationThe incidence and risk factors of arrhythmias in the early period after cardiac surgery in pediatric patients
The Turkish Journal of Pediatrics 2008; 50: 549-553 Original The incidence and risk factors of arrhythmias in the early period after cardiac surgery in pediatric patients Selman Vefa Yıldırım 1, Kürşad
More informationBronchoscopes: Occurrence and Management
ORIGIAL ARTICLES Res tk iratory Acidosis wi the Small Ston-Hopkins Bronchoscopes: Occurrence and Management Kang H. Rah, M.D., Arnold M. Salzberg, M.D., C. Paul Boyan, M.D., and Lazar J. Greenfield, M.D.
More informationWeaning from Mechanical Ventilation. Dr Azmin Huda Abdul Rahim
Weaning from Mechanical Ventilation Dr Azmin Huda Abdul Rahim Content Definition Classification Weaning criteria Weaning methods Criteria for extubation Introduction Weaning comprises 40% of the duration
More informationSurviving Sepsis Campaign. Guidelines for Management of Severe Sepsis/Septic Shock. An Overview
Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis/Septic Shock An Overview Mechanical Ventilation of Sepsis-Induced ALI/ARDS ARDSnet Mechanical Ventilation Protocol Results: Mortality
More informationHemodynamic Monitoring
Perform Procedure And Interpret Results Hemodynamic Monitoring Tracheal Tube Cuff Pressure Dean R. Hess PhD RRT FAARC Hemodynamic Monitoring Cardiac Rate and Rhythm Arterial Blood Pressure Central Venous
More information1. When a patient fails to ventilate or oxygenate adequately, the problem is caused by pathophysiological factors such as hyperventilation.
Chapter 1: Principles of Mechanical Ventilation TRUE/FALSE 1. When a patient fails to ventilate or oxygenate adequately, the problem is caused by pathophysiological factors such as hyperventilation. F
More informationCongenital Heart Defects
Normal Heart Congenital Heart Defects 1. Patent Ductus Arteriosus The ductus arteriosus connects the main pulmonary artery to the aorta. In utero, it allows the blood leaving the right ventricle to bypass
More informationPULMONARY HYPERTENSION AFTER OPERATIONS FOR CONGENITAL HEART DISEASE: ANALYSIS OF RISK FACTORS AND MANAGEMENT
PULMONARY HYPERTENSION AFTER OPERATIONS FOR CONGENITAL HEART DISEASE: ANALYSIS OF RISK FACTORS AND MANAGEMENT Ko Bando, MD Mark W. Turrentine, MD Thomas G. Sharp, MD Yasuo Sekine, MD Thomas X. Aufiero,
More informationPPHN (see also ECMO guideline)
Children s Acute Transport Service Clinical Guidelines PPHN (see also ECMO guideline) Document Control Information Author P Brooke E.Randle Author Position Medical Student Consultant Document Owner E.
More information5/30/2014. Pulmonary Hypertension PULMONARY HYPERTENSION. mean PAP > 25 mmhg at rest. Disclosure: none
Disclosure: Pulmonary Hypertension none James Ramsay MD Medical Director, CV ICU, Moffitt Hospital, UCSF PULMONARY HYPERTENSION mean PAP > 25 mmhg at rest Pulmonary Hypertension and Right Ventricular Dysfunction:
More informationAirway Management in a Patient with Klippel-Feil Syndrome Using Extracorporeal Membrane Oxygenator
Airway Management in a Patient with Klippel-Feil Syndrome Using Extracorporeal Membrane Oxygenator Beckerman Z*, Cohen O, Adler Z, Segal D, Mishali D and Bolotin G Department of Cardiac Surgery, Rambam
More informationHandling Common Problems & Pitfalls During. Oxygen desaturation in patients receiving mechanical ventilation ACUTE SEVERE RESPIRATORY FAILURE
Handling Common Problems & Pitfalls During ACUTE SEVERE RESPIRATORY FAILURE Pravit Jetanachai, MD QSNICH Oxygen desaturation in patients receiving mechanical ventilation Causes of oxygen desaturation 1.
More informationPharmacology. Drugs affecting the Cardiovascular system (Antianginal Drugs)
Lecture 7 (year3) Dr Noor Al-Hasani Pharmacology University of Baghdad College of dentistry Drugs affecting the Cardiovascular system (Antianginal Drugs) Atherosclerotic disease of the coronary arteries,
More informationCardiovascular Pathophysiology: Right to Left Shunts aka Cyanotic Lesions
Cardiovascular Pathophysiology: Right to Left Shunts aka Cyanotic Lesions Ismee A. Williams, MD, MS iib6@columbia.edu Pediatric Cardiology Learning Objectives To discuss the hemodynamic significance of
More informationCardiovascular Pathophysiology: Right to Left Shunts aka Cyanotic Lesions Ismee A. Williams, MD, MS Pediatric Cardiology
Cardiovascular Pathophysiology: Right to Left Shunts aka Cyanotic Lesions Ismee A. Williams, MD, MS iib6@columbia.edu Pediatric Cardiology Learning Objectives To discuss the hemodynamic significance of
More informationAORTIC COARCTATION. Synonyms: - Coarctation of the aorta
AORTIC COARCTATION Synonyms: - Coarctation of the aorta Definition: Aortic coarctation is a congenital narrowing of the aorta, usually located after the left subclavian artery, near the ductus or the ligamentum
More informationCIRCULATION IN CONGENITAL HEART DISEASE*
THE EFFECT OF CARBON DIOXIDE ON THE PULMONARY CIRCULATION IN CONGENITAL HEART DISEASE* BY R. J. SHEPHARD From The Cardiac Department, Guy's Hospital Received July 26, 1954 The response of the pulmonary
More informationPulmonary Hypertension Perioperative Management
Pulmonary Hypertension Perioperative Management Bruce J Leone, MD Professor of Anesthesiology Chief, Neuroanesthesiology Vice Chair for Academic Affairs Mayo Clinic Jacksonville, Florida Introduction Definition
More informationCapnography: The Most Vital of Vital Signs. Tom Ahrens, PhD, RN, FAAN Research Scientist, Barnes-Jewish Hospital, St. Louis, MO May, 2017
Capnography: The Most Vital of Vital Signs Tom Ahrens, PhD, RN, FAAN Research Scientist, Barnes-Jewish Hospital, St. Louis, MO May, 2017 Assessing Ventilation and Blood Flow with Capnography Capnography
More informationStudy Of Effects Of Varying Durations Of Pre-Oxygenation. J Khandrani, A Modak, B Pachpande, G Walsinge, A Ghosh
ISPUB.COM The Internet Journal of Anesthesiology Volume 20 Number 1 J Khandrani, A Modak, B Pachpande, G Walsinge, A Ghosh Citation J Khandrani, A Modak, B Pachpande, G Walsinge, A Ghosh.. The Internet
More informationThe Blue Baby. Network Stabilisation of the Term Infant Study Day 15 th March 2017 Joanna Behrsin
The Blue Baby Network Stabilisation of the Term Infant Study Day 15 th March 2017 Joanna Behrsin Session Structure Definitions and assessment of cyanosis Causes of blue baby Structured approach to assessing
More informationExtracorporeal Membrane Oxygenation (ECMO)
Extracorporeal Membrane Oxygenation (ECMO) Policy Number: Original Effective Date: MM.12.006 05/16/2006 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 11/01/2014 Section: Other/Miscellaneous
More informationLab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide
Lab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide Main Idea: The function of the circulatory system is to maintain adequate blood flow to all tissues. Clinical
More informationBIOL 219 Spring Chapters 14&15 Cardiovascular System
1 BIOL 219 Spring 2013 Chapters 14&15 Cardiovascular System Outline: Components of the CV system Heart anatomy Layers of the heart wall Pericardium Heart chambers, valves, blood vessels, septum Atrioventricular
More informationLate pulmonary hypertension in preterm infants How to sort things out? V.Gournay, FCPC, La Martinique, Nov 23,2015
Late pulmonary hypertension in preterm infants How to sort things out? V.Gournay, FCPC, La Martinique, Nov 23,2015 Epidemiology Incidence of extreme prematurity (
More informationDoes Targeted Neonatal Echocardiography(TnECHO) can help prevent Postoperative Cardiorespiratory instability following PDA ligation?
Does Targeted Neonatal Echocardiography(TnECHO) can help prevent Postoperative Cardiorespiratory instability following PDA ligation? Amish Jain, Mohit Sahni, Afif El Khuffash, Arvind Sehgal, Patrick J
More informationCuffed Tracheal Tubes in Children - Myths and Facts. PD Dr. Markus Weiss Department of Anaesthesia University Children s Hospital Zurich Switzerland
Cuffed Tracheal Tubes in Children - Myths and Department of Anaesthesia University Children s Hospital Zurich Switzerland PRO Reduced gas leak, low fresh gas flow Decreased atmospheric pollution Constant
More informationNeonatal/Pediatric Cardiopulmonary Care. Persistent Pulmonary Hypertension of the Neonate (PPHN) PPHN. Other. Other Diseases
Neonatal/Pediatric Cardiopulmonary Care Other Diseases Persistent Pulmonary Hypertension of the Neonate (PPHN) PPHN 3 Also known as Persistent Fetal Circulation (PFC) Seen most frequently in term, post-term
More informationThe Vigileo monitor by Edwards Lifesciences supports both the FloTrac Sensor for continuous cardiac output and the Edwards PreSep oximetry catheter
1 2 The Vigileo monitor by Edwards Lifesciences supports both the FloTrac Sensor for continuous cardiac output and the Edwards PreSep oximetry catheter for continuous central venous oximetry (ScvO2) 3
More informationHeart Failure (HF) Treatment
Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and
More informationIndex. Note: Page numbers of article titles are in boldface type
Index Note: Page numbers of article titles are in boldface type A Acute coronary syndrome, perioperative oxygen in, 599 600 Acute lung injury (ALI). See Lung injury and Acute respiratory distress syndrome.
More informationIntra-operative Echocardiography: When to Go Back on Pump
Intra-operative Echocardiography: When to Go Back on Pump GREGORIO G. ROGELIO, MD., F.P.C.C. OUTLINE A. Indications for Intraoperative Echocardiography B. Role of Intraoperative Echocardiography C. Criteria
More informationEFFECTIVE CONTROL OF PULMONARY VASCULAR RESISTANCE WITH INHALED NITRIC OXIDE AFTER CARDIAC OPERATION
EFFECIVE CONROL OF PULMONARY VASCULAR RESISANCE WIH INHALED NIRIC OXIDE AFER CARDIAC OPERAION David A. Fullerton, MD Stephen D. Jones, MD James Jaggers, MD Fran Piedalue, RR Frederick L. Grover, MD Robert
More informationDuct Dependant Congenital Heart Disease
Children s Acute Transport Service Clinical Guidelines Duct Dependant Congenital Heart Disease This guideline has been agreed by both NTS & CATS Document Control Information Author CATS/NTS Author Position
More information7/4/2015. diffuse lung injury resulting in noncardiogenic pulmonary edema due to increase in capillary permeability
Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC, CEN, CNRN, CMSRN, NP Education Specialist LRM Consulting Nashville, TN Objectives Identify the 5 criteria for the diagnosis of ARDS. Discuss the common etiologies
More informationHOW LOW CAN YOU GO? HYPOTENSION AND THE ANESTHETIZED PATIENT.
HOW LOW CAN YOU GO? HYPOTENSION AND THE ANESTHETIZED PATIENT. Donna M. Sisak, CVT, LVT, VTS (Anesthesia/Analgesia) Seattle Veterinary Specialists Kirkland, WA dsisak@svsvet.com THE ANESTHETIZED PATIENT
More informationW. J. RUSSELL*, M. F. JAMES
Anaesth Intensive Care 2004; 32: 644-648 The Effects on Arterial Haemoglobin Oxygen Saturation and on Shunt of Increasing Cardiac Output with Dopamine or Dobutamine During One-lung Ventilation W. J. RUSSELL*,
More informationAbsent Pulmonary Valve Syndrome
Absent Pulmonary Valve Syndrome Fact sheet on Absent Pulmonary Valve Syndrome In this condition, which has some similarities to Fallot's Tetralogy, there is a VSD with narrowing at the pulmonary valve.
More informationCardiorespiratory Interactions:
Cardiorespiratory Interactions: The Heart - Lung Connection Jon N. Meliones, MD, MS, FCCM Professor of Pediatrics Duke University Medical Director PCVICU Optimizing CRI Cardiorespiratory Economics O2:
More informationNIV - BI-LEVEL POSITIVE AIRWAY PRESSURE (BIPAP)
Introduction NIV - BI-LEVEL POSITIVE AIRWAY PRESSURE (BIPAP) Noninvasive ventilation (NIV) is a method of delivering oxygen by positive pressure mask that allows for the prevention or postponement of invasive
More information5.8 Congenital Heart Disease
5.8 Congenital Heart Disease Congenital heart diseases (CHD) refer to structural or functional heart diseases, which are present at birth. Some of these lesions may be discovered later. prevalence of Chd
More informationChapter 9, Part 2. Cardiocirculatory Adjustments to Exercise
Chapter 9, Part 2 Cardiocirculatory Adjustments to Exercise Electrical Activity of the Heart Contraction of the heart depends on electrical stimulation of the myocardium Impulse is initiated in the right
More informationManaging Hypertension in the Perioperative Arena
Managing Hypertension in the Perioperative Arena Optimizing Perioperative Management Strategies for Hypertension in the Cardiac Surgical Patient Objectives: Treatment of hypertensive emergencies. ALBERT
More informationCase scenario V AV ECMO. Dr Pranay Oza
Case scenario V AV ECMO Dr Pranay Oza Case Summary 53 y/m, k/c/o MVP with myxomatous mitral valve with severe Mitral regurgitation underwent Mitral valve replacement with mini thoracotomy Pump time nearly
More informationNeal D. Hillman, MD a Ira M. Cheifetz, MD b Damian M. Craig, MS a Peter K. Smith, MD = Ross M. Ungerleider, MD a Jon N. Meliones, MD, FCCM b
INHALED NITRIC OXIDE, RIGHT VENTRICULAR EFFICIENCY, AND PULMONARY VASCULAR MECHANICS: SELECTIVE VASODILATION OF SMALL PULMONARY VESSELS DURING HYPOXIC PULMONARY VASOCONSTRICTION Neal D. Hillman, MD a Ira
More informationCardiac Emergencies in Infants. Michael Luceri, DO
Cardiac Emergencies in Infants Michael Luceri, DO October 7, 2017 I have no financial obligations or conflicts of interest to disclose. Objectives Understand the scope of congenital heart disease Recognize
More informationSWISS SOCIETY OF NEONATOLOGY. Prolonged arterial hypotension due to propofol used for endotracheal intubation in a newborn infant
SWISS SOCIETY OF NEONATOLOGY Prolonged arterial hypotension due to propofol used for endotracheal intubation in a newborn infant July 2001 2 Wagner B, Intensive Care Unit, University Children s Hospital
More informationStabilization and Transportation guidelines for Neonates and infants with Heart disease:
Stabilization and Transportation guidelines for Neonates and infants with Heart disease: Background: Referral Pediatric Cardiac Units, frequently receive neonates and infants referred and transported from
More informationPIAF study: Placental insufficiency and aortic isthmus flow Jean-Claude Fouron, MD
Dear colleagues, I would like to thank you very sincerely for agreeing to participate in our multicentre study on the clinical significance of recording fetal aortic isthmus flow during placental circulatory
More informationNON INVASIVE LIFE SAVERS. Non Invasive Ventilation (NIV)
Table 1. NIV: Mechanisms Of Action Decreases work of breathing Increases functional residual capacity Recruits collapsed alveoli Improves respiratory gas exchange Reverses hypoventilation Maintains upper
More informationPulmonary hypertension and right ventricular failure
Pulmonary hypertension and right ventricular failure Sven-Erik Ricksten Dept. Anaesthesiology and Intensive Care, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg,
More informationCardiovascular Physiology. Heart Physiology. Introduction. The heart. Electrophysiology of the heart
Cardiovascular Physiology Heart Physiology Introduction The cardiovascular system consists of the heart and two vascular systems, the systemic and pulmonary circulations. The heart pumps blood through
More informationDebate in Management of native COA; Balloon Versus Surgery
Debate in Management of native COA; Balloon Versus Surgery Dr. Amira Esmat, El Tantawy, MD Professor of Pediatrics Consultant Pediatric Cardiac Interventionist Faculty of Medicine Cairo University 23/2/2017
More informationOstium primum defects with cleft mitral valve
Thorax (1965), 20, 405. VIKING OLOV BJORK From the Department of Thoracic Surgery, University Hospital, Uppsala, Sweden Ostium primum defects are common; by 1955, 37 operated cases had been reported by
More informationAtrial Septostomy in HLHS and ECMO: Indications, Technique and Outcome
Atrial Septostomy in HLHS and ECMO: Indications, Technique and Outcome Dr Damien Kenny, MB, MD Assistant Professor of Pediatrics Director of the Cardiac Catheterization Hybrid Suite Co-Director of the
More informationLEFT HEART AND EXACERBATION OF LEFT HEART FAILURE
LEFT HEART AND EXACERBATION OF LEFT HEART FAILURE Concept Map Aetiology: left heart failure is a severe fatal state in which the left side of the human heart fails to properly pump adequate amount of blood
More informationOxygenation Failure. Increase FiO2. Titrate end-expiratory pressure. Adjust duty cycle to increase MAP. Patient Positioning. Inhaled Vasodilators
Oxygenation Failure Increase FiO2 Titrate end-expiratory pressure Adjust duty cycle to increase MAP Patient Positioning Inhaled Vasodilators Extracorporeal Circulation ARDS Radiology Increasing Intensity
More informationI. Subject: Continuous Positive Airway Pressure CPAP by Continuous Flow Device
I. Subject: Continuous Positive Airway Pressure CPAP by Continuous Flow Device II. Policy: Continuous Positive Airway Pressure CPAP by the Down's system will be instituted by Respiratory Therapy personnel
More informationTechniques for repair of complete atrioventricular septal
No Ventricular Septal Defect Patch Atrioventricular Septal Defect Repair Carl L. Backer, MD *, Osama Eltayeb, MD *, Michael C. Mongé, MD *, and John M. Costello, MD For the past 10 years, our center has
More informationOriginal/Research Articles Analysis of Severe Pulmonary Hypertension
Reced. : 24.11.09 Taken from CD. 10bhjj03 3rd proof Original/Research Articles Analysis of Severe Pulmonary Hypertension Shilpa Rao*, Manjula Sarkar**, Sarla Pandya*** Abstract Pulmonary hypertension may
More informationThe Challenging Pediatric Cardiac Patient. Edmund Jooste
The Challenging Pediatric Cardiac Patient Edmund Jooste A 5 -year old female with hypoplastic left heart syndrome s/p the Fontan procedure presents for laparoscopic appendectomy for acute appendicitis.
More informationPHYSIOLOGY MeQ'S (Morgan) All the following statements related to blood volume are correct except for: 5 A. Blood volume is about 5 litres. B.
PHYSIOLOGY MeQ'S (Morgan) Chapter 5 All the following statements related to capillary Starling's forces are correct except for: 1 A. Hydrostatic pressure at arterial end is greater than at venous end.
More informationTreatment of T Angina reatment of By Ali Alalawi
Treatment of Angina By Ali Alalawi Determinants of Oxygen Demand Need to improve ratio of: Coronary blood flow / cardiac work Or Cardiac O2 Supply / Cardiac Requirement Coronary Circulation vs Other Circulation
More informationSURGICAL TREATMENT AND OUTCOME OF CONGENITAL HEART DISEASE
SURGICAL TREATMENT AND OUTCOME OF CONGENITAL HEART DISEASE Mr. W. Brawn Birmingham Children s Hospital. Aims of surgery The aim of surgery in congenital heart disease is to correct or palliate the heart
More information